Skip to main navigation
elicio logo
  • Overview
  • News & Events
    Press Releases Events Presentations
  • Stock Information
    Stock Quote & Chart
  • Corporate Governance
    Documents & Charters Management Team Board of Directors Committee Composition
  • Financial & Filings
    SEC Filings
  • IR Resources
    Investor FAQs Email Alerts Contact IR

Events

Upcoming Events

December 6, 2023 10:30 AM EST
H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
Listen to webcast
Add to Outlook
Add to Google Calendar

Past Events

October 2, 2023
T cell responses and clinical outcomes in pancreatic and colorectal cancer patients with Minimal Residual Disease in AMPLIFY-201, a Phase 1 trial of a first-in-class Amphiphile lymph node targeted mutant KRAS vaccine (AACR)
Listen to webcast
September 13, 2023 9:30 AM EDT
H.C. Wainwright 25th Annual Global Investment Conference

Listen to webcast here. (Link only available for registered conference attendees)

June 12, 2023
AMPLIFY-201, a first-in-human safety and efficacy trial of adjuvant ELI-002 2P immunotherapy for patients with high-relapse risk G12D- or G12R- mutated pancreatic and colorectal cancer (ASCO)
Listen to webcast

Contact Investor Relations

Phone: +1 857-209-0153
Email: IR@elicio.com

  • © Elicio Therapeutics Inc. All Rights Reserved. 2023
  • Facebook
  • Twitter
  • LinkedIn
  • RSS